BIOMAT Database Logo BIOMAT Database Logo

Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist. 1998

C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
Novartis Institute for Medical Sciences, London.

1. The in vitro and in vivo pharmacology of SDZ NKT 343 (2-nitrophenyl-carbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide), a novel tachykinin NK1 receptor antagonist was investigated. 2. SDZ NKT 343 inhibited [3H]-substance P binding to the human NK1 receptor in transfected Cos-7 cell membranes (IC50 = 0.62+/-0.11 nM). In comparison, in the same assay Ki values for FK888, CP 99,994, SR 140,333 and RPR 100,893 were 2.13+/-0.04 nM, 0.96+/-0.20 nM, 0.15+/-0.06 nM and 1.77+/-0.41 nM, respectively. SDZ NKT 343 showed a markedly lower affinity at rat NK1 receptors in whole forebrain membranes (IC50 = 451+/-139 nM). 3. SDZ NKT 343 caused an increase in EC50 as well as reduction in the number of binding sites (Bmax) determined for [3H]-substance P, suggesting a non-competitive interaction at the human NK1 receptor. SDZ NKT 343 also caused a reduction in the maximum elevation of [Ca2+]i evoked by substance P (SP) in human U373MG cells and depressed the maximum [Sar9]SP sulphone-induced contraction of the guinea-pig isolated ileum. The antagonism of SP effects on U373MG cells by SDZ NKT 343 was reversible. 4. SDZ NKT 343 showed weak affinity to human NK2 and NK3 receptors in transfected Cos-7 cells (Ki of 0.52+/-0.04 microM and 3.4+/-1.2 microM, respectively). SDZ NKT 343 was inactive in a broad array of binding assays including the bradykinin B2 receptor the histamine H1 receptor, opiate receptors and adrenoceptors. SDZ NKT 343 only weakly inhibited the voltage-activated Ca2+ and Na+ currents in guinea-pig dorsal root ganglion neurones. The enantiomer of SDZ NKT 343, (R,R)-SDZ NKT 343 was about 1000 times less active at human NK1 receptors expressed in Cos-7 cell membranes. 5. Contractions of the guinea-pig ileum by [Sar9]SP sulphone were inhibited by SDZ NKT 343 in a concentration-dependent manner, with an IC50 = 1.60+/-0.94 nM, while the enantiomer (R,R)-SDZ NKT 343 was 100 times less active (IC50 = 162+/-26 nM). In comparison, in the same assay IC50 values for other NK1 receptor antagonists CP 99,994, SR 140,333, RPR 100,893 and FK 888 were 2.90+/-07 nM, 0.14+/-0.02 nM, 11.4+/-2.9 nM and 2.4+/-0.83 nM, respectively. 6. In anaesthetized guinea-pigs i.v. administered SDZ NKT 343 antagonized [Sar9]SP sulphone-evoked bronchoconstriction (70% reduction at 0.4 mg kg(-1), i.v.). Basal airway resistance, mean arterial blood pressure and heart rate were not affected. 7. In conclusion, SDZ NKT 343 is a highly selective NK1 receptor antagonist with high potency at the human and guinea-pig receptors. SDZ NKT 343 may be used as a potential novel therapeutic agent in human diseases where NK1 receptor hyperfunction is involved.

UI MeSH Term Description Entries
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005727 Ganglia, Spinal Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain. Dorsal Root Ganglia,Spinal Ganglia,Dorsal Root Ganglion,Ganglion, Spinal,Ganglia, Dorsal Root,Ganglion, Dorsal Root,Spinal Ganglion
D005849 Gerbillinae A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys. Gerbils,Jird,Meriones,Psammomys,Rats, Sand,Gerbil,Jirds,Merione,Rat, Sand,Sand Rat,Sand Rats
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea

Related Publications

C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
The effects of SDZ NKT 343, a potent NK1 receptor antagonist, on cutaneous responses of primate spinothalamic tract neurones sensitized by intradermal capsaicin injection.
August 1998, Experimental brain research,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
December 1995, British journal of pharmacology,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
Aprepitant--a novel NK1-receptor antagonist.
December 2003, Expert opinion on pharmacotherapy,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in rats.
February 2000, Biological & pharmaceutical bulletin,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002.
March 2004, Naunyn-Schmiedeberg's archives of pharmacology,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist.
January 1998, European journal of pharmacology,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
February 1993, European journal of pharmacology,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist.
December 1995, European journal of pharmacology,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
The pharmacology of SDZ EAA 494, a competitive NMDA antagonist.
December 1994, Neurochemistry international,
C S Walpole, and M C Brown, and I F James, and E A Campbell, and P McIntyre, and R Docherty, and S Ko, and L Hedley, and S Ewan, and K H Buchheit, and L A Urban
Effect of a novel NK1 receptor selective antagonist (NKP608) on citric acid induced cough and airway obstruction.
January 2004, Pulmonary pharmacology & therapeutics,
Copied contents to your clipboard!